National trends in neonatal diagnoses recorded at hospital discharge in Kazakhstan, 2014–2024

Balzhan N. Tatibekova, Adema K Sagatbaeva, Bauyrzhan N Tatibekov

BMJ Paediatrics Open, 2026

Full text Open access: Gold Metadata (CSL-JSON)
DOI 10.1136/bmjpo-2026-005122
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

BACKGROUND: Declining neonatal mortality has increased the number of surviving newborns; however, in health systems without validated neonatal morbidity indicators, population-level patterns of diagnoses recorded at hospital discharge remain poorly characterised. OBJECTIVE: To characterise national trends in neonatal mortality, survival among infants with extremely low and very low birth weight, and International Classification of Diseases 10th revision (ICD-10) diagnoses recorded at discharge among surviving newborns in Kazakhstan from 2014 to 2024. METHODS: We conducted a nationwide retrospective population-based study using de-identified administrative health data covering all live births in Kazakhstan from 2014 to 2024. Temporal trends in neonatal mortality, survival among infants with extremely low and very low birth weight and recorded primary ICD-10 diagnoses at discharge were assessed. RESULTS: Among 4 437 357 live births, neonatal mortality decreased from 6.2 to 4.0 per 1000 live births, whereas the proportion of surviving newborns with a recorded primary diagnosis at discharge increased from 4.9% to 16.7% (relative risk 3.41; 95% CI 3.36 to 3.46; p<0.001). By 2024, P91, P59 and P22 accounted for 88.4% of recorded primary diagnoses. The increase in P91 diagnoses occurred without a corresponding increase in the proportion of newborns weighing <2500 g. CONCLUSION: Declining neonatal mortality was accompanied by an increase and a changing distribution of recorded diagnoses among surviving newborns. These data cannot determine individual post-discharge follow-up needs but may provide an initial population-level basis for planning subsequent clinical risk stratification after discharge.